Exelixis
EXEL
#1661
Rank
S$16.82 B
Marketcap
S$66.95
Share price
-1.01%
Change (1 day)
27.86%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company